Showing results (541-550 of 2,002) with videos related to

Sort By:
Pageof 201
Endocrine, Metabolic & Immune Disorders Drug Targets|September 15, 2023
Glutaric Acidemia Type 1: Diagnosis, Clinical features, and Outcome in a Portuguese CohortPatrícia Lipari Pinto, Beatriz Câmara, Cristina Florindo, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 13, 2023
Association of Obesity based on Different Metabolic Status with Risk of Gout Occurrence in Patients: A National StudyYanyan Wang, Luna Liu, Shizhan Ma, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|August 29, 2023
Benefits of Mediterranean and Japanese Diets among Nurses: A Scoping Literature ReviewElsa Vitale
Endocrine, Metabolic & Immune Disorders Drug Targets|August 29, 2023
Hypothyroidism in Older Adults: A Narrative ReviewVincenzo Fiore, Alessandra Barucca, S Barraco, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|August 29, 2023
Combination Therapy: A New Tool for the Management of ObesityPranav Kumar Prabhakar
Endocrine, Metabolic & Immune Disorders Drug Targets|September 11, 2023
Interleukin (IL)-23, IL-31, and IL-33 Play a Role in the Course of Autoimmune Endocrine DiseasesSzymon Janyga, Dariusz Kajdaniuk, Zenon Czuba, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 11, 2023
Investigation on Anti-diabetic Efficacy of a Cucurbitaceae Food Plant from the North-East Region of India: Exploring the Molecular Mechanism through Modulation of Oxidative Stress and Glycosylated Hemoglobin (HbA1c)Sandipan Jana, Srijon Gayen, Barun Das Gupta, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|August 1, 2023
The Reconstitution of T-cells after Allogeneic Hematopoietic Stem Cell Transplant in a Pediatric Patient with Congenital Amegakaryocytic Thrombocytopenia (CAMT)Shideh Namazi Bayegi, Amir Ali Hamidieh, Maryam Behfar, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|August 22, 2023
New Promising Routes in Peptic Ulcers: Toll-like Receptors and SemaphorinsTeresa V Jacob, Gaurav M Doshi
Endocrine, Metabolic & Immune Disorders Drug Targets|August 22, 2023
Replacement Dose for Overt Hypothyroidism Induced by Programmed Cell Death Protein 1 Antibodies May Be Higher than RecommendedQian Zhang, Yao Zhang, Huijuan Zhu, et al.
Pageof 201